Alka C. Veerisetty

485 citations
17 papers · 373 indexed · h-index 11

Alka C. Veerisetty

17 papers receiving 356 citations

Peers

Alka C. Veerisetty
Comparison fields: 5 of 61
  • Rheumatology 178
  • Immunology and Allergy 67
  • Cancer Research 77
  • Cell Biology 71
  • Molecular Biology 233
Replace Louise H. W. Kung with:
Louise H. W. Kung Australia
Katarzyna A. Piróg United Kingdom
Claudine G. James Canada
Jong‐Kyung Sonn South Korea
Kirsty L. Culley United States
Mei Zhu United States
Jamie Soul United Kingdom
S.H. Madsen Denmark
Gail C. Jackson United Kingdom
Deborah Bielser United States
Alka C. Veerisetty relative to Louise H. W. Kung Australia Louise H. W. Kung's profile →
Citations per field
00.5×1.5×2.0×
Louise H. W. Kung · 1×
Citations per year

Countries citing papers authored by Alka C. Veerisetty

Since Specialization
Citations

This map shows the geographic impact of Alka C. Veerisetty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alka C. Veerisetty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alka C. Veerisetty more than expected).

Fields of papers citing papers by Alka C. Veerisetty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alka C. Veerisetty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alka C. Veerisetty. The network helps show where Alka C. Veerisetty may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alka C. Veerisetty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alka C. Veerisetty Line = papers co-authored together Alka C. Veerisetty links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20233
2 20236
3 20238
4 202123
5 20219
6 202015
7 20191
8 201825
9 201811
10 201712
11 201530
12 201330
13 201135
14 201010
15 200952
16 200830
17 200873

About Alka C. Veerisetty

Alka C. Veerisetty is a scholar working on Rheumatology, Cancer Research and Immunology and Allergy, having authored 17 papers that have together received 373 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (12 papers), interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cancer-related molecular mechanisms research (3 papers), Lower Extremity Biomechanics and Pathologies (2 papers), Cell Adhesion Molecules Research (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Rheumatology (178 citations), Immunology and Allergy (67 citations) and Cancer Research (77 citations). Alka C. Veerisetty has collaborated with scholars based in United States. Frequent co-authors include Karen L. Posey, Jacqueline T. Hecht, Françoise Coustry, Joseph L. Alcorn, Kurt D. Hankenson, Paul Börnstein, Peiman Liu, Jack Lawler, Mohammad Sharif Hossain and Brian J. Poindexter. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026